Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 15 studies | 33% ± 17% | |
| glutamatergic neuron | 13 studies | 56% ± 27% | |
| astrocyte | 12 studies | 34% ± 13% | |
| oligodendrocyte | 12 studies | 30% ± 10% | |
| macrophage | 11 studies | 32% ± 13% | |
| microglial cell | 11 studies | 28% ± 10% | |
| GABAergic neuron | 10 studies | 47% ± 24% | |
| oligodendrocyte precursor cell | 9 studies | 31% ± 9% | |
| fibroblast | 9 studies | 26% ± 11% | |
| pericyte | 8 studies | 28% ± 14% | |
| plasmacytoid dendritic cell | 8 studies | 23% ± 7% | |
| myeloid cell | 8 studies | 25% ± 10% | |
| neuron | 7 studies | 41% ± 15% | |
| interneuron | 6 studies | 51% ± 21% | |
| retinal ganglion cell | 6 studies | 52% ± 14% | |
| epithelial cell | 6 studies | 34% ± 17% | |
| dendritic cell | 6 studies | 23% ± 7% | |
| smooth muscle cell | 6 studies | 19% ± 3% | |
| retina horizontal cell | 5 studies | 28% ± 11% | |
| adipocyte | 5 studies | 25% ± 6% | |
| mast cell | 5 studies | 21% ± 8% | |
| endothelial cell of lymphatic vessel | 5 studies | 26% ± 7% | |
| monocyte | 5 studies | 26% ± 8% | |
| club cell | 5 studies | 20% ± 7% | |
| type I pneumocyte | 5 studies | 20% ± 5% | |
| type II pneumocyte | 5 studies | 23% ± 6% | |
| granule cell | 4 studies | 38% ± 11% | |
| retinal pigment epithelial cell | 4 studies | 39% ± 19% | |
| amacrine cell | 4 studies | 26% ± 7% | |
| T cell | 4 studies | 20% ± 5% | |
| hematopoietic precursor cell | 3 studies | 18% ± 2% | |
| GABAergic interneuron | 3 studies | 43% ± 2% | |
| plasma cell | 3 studies | 22% ± 3% | |
| CD4-positive, alpha-beta T cell | 3 studies | 17% ± 3% | |
| cardiac muscle cell | 3 studies | 17% ± 1% | |
| mononuclear phagocyte | 3 studies | 21% ± 6% | |
| GABAergic amacrine cell | 3 studies | 33% ± 12% | |
| Mueller cell | 3 studies | 22% ± 6% | |
| OFF-bipolar cell | 3 studies | 31% ± 11% | |
| ON-bipolar cell | 3 studies | 30% ± 12% | |
| glycinergic amacrine cell | 3 studies | 26% ± 6% | |
| retinal rod cell | 3 studies | 20% ± 3% | |
| hepatocyte | 3 studies | 43% ± 29% | |
| alveolar macrophage | 3 studies | 35% ± 8% | |
| ciliated cell | 3 studies | 21% ± 4% | |
| natural killer cell | 3 studies | 24% ± 5% | |
| lymphocyte | 3 studies | 35% ± 8% | |
| goblet cell | 3 studies | 41% ± 24% | |
| transit amplifying cell | 3 studies | 36% ± 27% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 6559.21 | 1445 / 1445 | 100% | 35.92 | 183 / 183 |
| prostate | 100% | 7507.47 | 245 / 245 | 100% | 33.37 | 500 / 502 |
| skin | 100% | 5398.27 | 1807 / 1809 | 100% | 40.85 | 470 / 472 |
| bladder | 100% | 7800.81 | 21 / 21 | 99% | 23.26 | 501 / 504 |
| breast | 100% | 6148.96 | 459 / 459 | 99% | 33.94 | 1111 / 1118 |
| stomach | 100% | 5965.33 | 359 / 359 | 99% | 26.76 | 284 / 286 |
| thymus | 100% | 7949.19 | 653 / 653 | 99% | 28.47 | 599 / 605 |
| lung | 100% | 7651.45 | 578 / 578 | 99% | 25.76 | 1143 / 1155 |
| brain | 99% | 13352.91 | 2611 / 2642 | 100% | 42.92 | 704 / 705 |
| intestine | 100% | 7888.76 | 966 / 966 | 99% | 21.81 | 520 / 527 |
| uterus | 100% | 9487.59 | 170 / 170 | 98% | 22.06 | 452 / 459 |
| kidney | 100% | 5260.71 | 89 / 89 | 97% | 20.38 | 878 / 901 |
| ovary | 100% | 7950.88 | 180 / 180 | 97% | 19.17 | 415 / 430 |
| pancreas | 97% | 2597.20 | 317 / 328 | 98% | 21.54 | 175 / 178 |
| adrenal gland | 100% | 6216.09 | 258 / 258 | 93% | 26.14 | 213 / 230 |
| liver | 98% | 3353.34 | 222 / 226 | 94% | 15.60 | 380 / 406 |
| adipose | 100% | 6072.69 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 7149.73 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 29.96 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 25.06 | 29 / 29 |
| spleen | 100% | 8099.96 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 22.55 | 45 / 45 |
| muscle | 100% | 4432.12 | 800 / 803 | 0% | 0 | 0 / 0 |
| heart | 96% | 3981.34 | 826 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 95% | 4500.36 | 886 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0140754 | Biological process | reorganization of cellular membranes to establish viral sites of replication |
| GO_0007165 | Biological process | signal transduction |
| GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
| GO_0048015 | Biological process | phosphatidylinositol-mediated signaling |
| GO_0044788 | Biological process | modulation by host of viral process |
| GO_0016310 | Biological process | phosphorylation |
| GO_0006661 | Biological process | phosphatidylinositol biosynthetic process |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005925 | Cellular component | focal adhesion |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0030660 | Cellular component | Golgi-associated vesicle membrane |
| GO_0045296 | Molecular function | cadherin binding |
| GO_0005524 | Molecular function | ATP binding |
| GO_0016301 | Molecular function | kinase activity |
| GO_0004430 | Molecular function | 1-phosphatidylinositol 4-kinase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PI4KA |
| Protein name | Phosphatidylinositol 4-kinase alpha 1-phosphatidylinositol 4-kinase (EC 2.7.1.67) Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) (Phosphatidylinositol 4-Kinase III alpha) |
| Synonyms | PIK4CA PIK4 |
| Description | FUNCTION: Acts on phosphatidylinositol (PtdIns) in the first committed step in the production of the second messenger inositol-1,4,5,-trisphosphate. . |
| Accessions | A8MTF1 ENST00000449120.1 ENST00000399213.2 P42356 C9JLI1 ENST00000255882.11 [P42356-1] |